Literature DB >> 30037337

Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis.

Martina Spaziante1,2, Giancarlo Ceccarelli1,2, Samir Al Moghazi1,2, Francesco Alessandri2,3, Mario Venditti4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30037337      PMCID: PMC6057063          DOI: 10.1186/s13054-018-2116-8

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
We read with interest the study by Thomas-Rüddel et al. [1] evaluating the influence of specific pathogens and different foci of infections on serum procalcitonin (PCT) concentrations. The authors concluded that PCT levels were higher in patients with Gram-negative bacteremia compared with patients with Gram-positive or fungal diseases, whereas urogenital and abdominal foci of infection were associated with twofold increased PCT values, independent of causative pathogen. Unfortunately, this study did not provide data on PCT trends in patients affected by endovascular infections. We recently collected a small series of 13 cases of endovascular infections caused by thrombophlebitis due to Gram-negative bacilli (GNB) in the intensive care unit (ICU) of a large University Hospital in Italy. The mean age of patients enrolled was 59.2 ± 13.6 years with a predominance of male sex (61.5%); the mean SAPS II at the admission was 39.7 ± 8.1 points and the most frequent cause of ICU admission was a recent polytrauma (84.6%). All patients had persistent bacteremia despite administration of in vitro active antibiotics and removal of intravascular devices. The diagnosis of septic thrombophlebitis was corroborated by CT scan (53.8%) or echodoppler (46.2%), and thrombus appositions mainly involved aortic trunks (61.5%). The blood isolates were four Klebsiella pneumoniae, four Acinetobacter baumannii, one Enterobacter spp., one Pseudomonas aeruginosa, one Morganella morganii, one Providencia rettgeri, and one Klebsiella oxytoca. Despite the prolonged duration of bacteremia and the appropriate antibiotic therapy, all patients showed an indolent clinical course, with no multi-organ failure, prompt clinical improvement, and rapid decrease of plasma PCT concentrations within normal ranges after the onset of septic episodes (Fig. 1).
Fig. 1

Clinical and microbiological course of GNB septic thrombophlebitis in critically ill patients. Clinical improvement was defined as withdrawal of inotropic support and fever < 38 °C. The median values (with range) are shown

Clinical and microbiological course of GNB septic thrombophlebitis in critically ill patients. Clinical improvement was defined as withdrawal of inotropic support and fever < 38 °C. The median values (with range) are shown As previously reported, PCT is produced in response to inflammatory cytokines and bacterial endotoxins [2]. In our cases the rapid decrease of PCT, followed by a stable normalization of serum concentration despite persistence of bacteremia, could be explained with the well-known mechanism of immune tolerance: in fact the selective blocks of some pro-inflammatory pathways, activated by bacterial endotoxins or cytokines, could impact on the production of PCT and favor a long indolent clinical course, even in the face of microbial eradication failure [3]. In conclusion, we think that our data could contribute to complete the results of Thomas-Rüddel et al. and are worthy of being further investigated in a larger series of cases. Physicians should be aware that serum PCT measurements should be interpreted with caution in assessing the clinical course of GNB endovascular infections. In this setting performance of serial blood cultures seems to remain the most adequate guide to therapy [1, 4].
  4 in total

1.  Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.

Authors:  Sheng Tao Yan; Li Chao Sun; Hong Bing Jia; Wen Gao; Jian Ping Yang; Guo Qiang Zhang
Journal:  Am J Emerg Med       Date:  2016-12-10       Impact factor: 2.469

Review 2.  Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases.

Authors:  David S Schneider; Janelle S Ayres
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

3.  Follow-up Blood Cultures: A 2.0 Diagnostic Tool in Patients With Gram-Negative Bacteremia and Septic Thrombophlebitis.

Authors:  Giancarlo Ceccarelli; Simone Giuliano; Marco Falcone; Mario Venditti
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

4.  Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia.

Authors:  Daniel O Thomas-Rüddel; Bernhard Poidinger; Matthias Kott; Manfred Weiss; Konrad Reinhart; Frank Bloos
Journal:  Crit Care       Date:  2018-05-13       Impact factor: 9.097

  4 in total
  4 in total

1.  Procalcitonin in the Assessment of Ventilator Associated Pneumonia: A Systematic Review.

Authors:  Francesco Alessandri; Francesco Pugliese; Silvia Angeletti; Massimo Ciccozzi; Alessandro Russo; Claudio M Mastroianni; Gabriella d'Ettorre; Mario Venditti; Giancarlo Ceccarelli
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Evaluation of the significance of interleukin-6 in the diagnosis of postoperative pneumonia: a prospective study.

Authors:  Wei Chen; Kai Zhong; Yan Guan; Hai Tao Zhang; He Zhang; Tuo Pan; Jun Pan; Dong Jin Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-07-07       Impact factor: 2.174

3.  A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit.

Authors:  Monica Basso; Carolina Venditti; Giammarco Raponi; Anna Sara Navazio; Francesco Alessandri; Emanuela Giombini; Carla Nisii; Antonino Di Caro; Mario Venditti
Journal:  Infect Drug Resist       Date:  2019-08-02       Impact factor: 4.003

4.  Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside.

Authors:  Alessandra Oliva; Ambrogio Curtolo; Lorenzo Volpicelli; Francesco Cogliati Dezza; Massimiliano De Angelis; Sara Cairoli; Donatella Dell'Utri; Bianca Maria Goffredo; Giammarco Raponi; Mario Venditti
Journal:  Antibiotics (Basel)       Date:  2021-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.